Table 1 Baseline clinical characteristics of patients (n = 86)
| Â | No | % |
|---|---|---|
Age (years)a | 49.21 ± 9.91(25 ~ 70) | |
  < 40 | 15 | 17.44 |
 40 ~ 49 | 27 | 31.40 |
 50 ~ 59 | 33 | 38.37 |
  ≥ 60 | 11 | 12.79 |
Body mass index (kg/m2) | 22.96 ± 3.01 (16.94 ~ 33.71) | |
  < 18 | 2 | 2.33 |
 18 ~ 23.9 | 52 | 60.47 |
 24 ~ 27.9 | 26 | 30.23 |
  ≥ 28 | 3 | 3.49 |
 NA | 3 | 3.49 |
FIGO stage | ||
 I | 56 | 65.12 |
  IA | 25 | 29.07 |
  IB | 2 | 2.33 |
  IC | 29 | 33.72 |
   IC1 | 13 | 15.12 |
   IC2 | 9 | 10.47 |
   IC3 | 2 | 2.33 |
   IC NA | 5 | 5.81 |
 II | 3 | 3.49 |
  IIA | 0 | 0 |
  IIB | 3 | 3.49 |
 III | 24 | 27.91 |
  IIIA | 4 | 4.65 |
  IIIB | 1 | 1.16 |
  IIIC | 19 | 22.09 |
 IV | 3 | 3.49 |
BRCA mutation (n = 15) | ||
 + | 1 | 6.67 |
 - | 13 | 86.67 |
 Unknown significance mutation | 1 | 6.67 |
Endometriosis | 16 | 18.60 |
Thrombosis | 8 | 9.30 |
 Preoperative | 4 | 4.65 |
 postoperative | 4 | 4.65 |
CDCb | 31 | 36.05 |
 Hypertension | 16 | 18.60 |
 Diabetes | 3 | 3.49 |
 Heart disease | 3 | 3.49 |
 Cerebral infarction | 6 | 6.98 |
 Other cancer history | 4 | 4.65 |
  Hepatic cancer | 1 | 1.16 |
  Breast cancer | 1 | 1.16 |
  Cervical cancer | 1 | 1.16 |
  Endometrial cancer | 1 | 1.16 |
 Hepatitis | 2 | 2.33 |
 Systemic lupus erythematosus | 1 | 1.16 |
 Rheumatoid arthritis | 1 | 1.16 |
 Bronchial asthma | 1 | 1.16 |
 Hypothyroidism | 1 | 1.16 |
 Moyamoya disease | 1 | 1.16 |
 Tuberculosis | 1 | 1.16 |
American Society of Anesthesiologists class (ASA) | ||
 I | 7 | 8.14 |
 II | 39 | 45.35 |
 III | 31 | 36.05 |
 IV | 3 | 3.49 |
 NA | 6 | 6.98 |
Preoperative laboratory test | ||
 CA125(U/ml) a | 601.48 ± 1546.66(9.16 ~ 9035.00) | |
  Normal (< 35) | 17 | 19.77 |
  35 ~ 99 | 16 | 18.60 |
  100 ~ 499 | 23 | 26.74 |
  500 ~ 999 | 4 | 4.65 |
   ≥ 1000 | 10 | 11.63 |
  NA | 16 | 18.60 |
 CA19–9(U/ml) a | 1575.97 ± 11,885.76(0.60 ~ 96,649.00) | |
  Normal (< 37) | 36 | 41.86 |
  37 ~ 99 | 13 | 15.12 |
  100 ~ 499 | 14 | 16.28 |
   ≥ 500 | 2 | 2.33 |
  NA | 21 | 24.42 |
 HE4 (pM) a | 105.37 ± 102.93(14.00 ~ 669.00) | |
  Normal (< 140) | 45 | 52.33 |
  140 ~ 499 | 12 | 13.95 |
   ≥ 500 | 1 | 1.16 |
  NA | 28 | 32.56 |
 Serum albumin (g/l) a | 40.74 ± 4.47(31.10 ~ 51.60) | |
   < 40 | 31 | 36.05 |
   ≥ 40 | 38 | 44.19 |
  NA | 17 | 19.77 |
 Prealbumin (mg/l) a | 194.65 ± 56.29(58.00 ~ 332.00) | |
   < 170 | 20 | 23.26 |
   ≥ 170 | 43 | 50.00 |
  NA | 23 | 26.74 |
 D-Dimer (ug/ml) a | 2.21 ± 3.19(0.03 ~ 12.86) | |
   < 3.5 | 47 | 54.65 |
  ≥ 3.5 | 9 | 10.47 |
  NA | 30 | 34.88 |
 Ca2+(mmol/l) a | 2.32 ± 0.25(1.90 ~ 3.50) | |
   < 2.11 | 7 | 8.14 |
  2.11 ~ 2.52 | 54 | 62.79 |
   > 2.52 | 7 | 8.14 |
  NA | 18 | 20.93 |